A Habtemariam Selected Research

RM175

1/2010	In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.
6/2005	Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Habtemariam Research Topics

Disease

2	Neoplasms (Cancer) 02/2016 - 01/2010
2	Colorectal Neoplasms (Colorectal Cancer) 02/2016 - 06/2005
1	Breast Neoplasms (Breast Cancer) 01/2010
1	Carcinoma (Carcinomatosis) 01/2010
1	Neoplasm Metastasis (Metastasis) 01/2010

Drug/Important Bio-Agent (IBA)

3	RutheniumIBA 02/2016 - 06/2005
2	RM175IBA 01/2010 - 06/2005
1	Proteins (Proteins, Gene)FDA Link 02/2016
1	Cisplatin (Platino)FDA LinkGeneric 02/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2016
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	diphenyl (biphenyl)IBA 01/2010
1	Matrix Metalloproteinases (MMPs)IBA 01/2010
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 01/2010
1	Human Serum Albumin FDA LinkGeneric 01/2010
1	CollagenIBA 01/2010
1	Fibronectins (Fibronectin)IBA 01/2010
1	Lysine (L-Lysine)FDA Link 01/2010
1	OsmiumIBA 01/2010

Therapy/Procedure

1	Radiotherapy 02/2016
1	Therapeutics 02/2016
1	Drug Therapy (Chemotherapy) 02/2016
1	Aftercare (After-Treatment) 01/2010